QT
IMCR icon

Quantbot Technologies’s Immunocore IMCR Stock Holding History

Quantbot Technologies’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,500
Closed -$97.5K – 1663
2024
Q1 		$97.5K Buy
+1,500
New +$103K 0.01% 1180
2023
Q2 		– Sell
-1,800
Closed -$89K – 1742
2023
Q1 		$89K Sell
1,800
-5,600
-76% -$315K 0.01% 1123
2022
Q4 		$422K Buy
7,400
+3,218
+77% +$181K 0.03% 639
2022
Q3 		$196K Buy
+4,182
New +$199K 0.01% 886

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Quantbot Technologies's IMCR Position: Q2 2024 in Review

Quantbot Technologies sold out of Immunocore (IMCR) in Q2 2024, closing a stake of 1,500 shares — an estimated $97.5K sold.

Quantbot Technologies first reported a position in IMCR in Q3 2022 and held it in 4 quarters. The position peaked at $422K in Q4 2022. 138 funds tracked by Wall St. Rank hold IMCR as of Q2 2024.

  • Quantbot Technologies reported no remaining Immunocore position as of Q2 2024 after selling out during the quarter.
  • Quantbot Technologies sold 1,500 Immunocore shares in Q2 2024, an estimated $97.5K.
  • Quantbot Technologies first reported a position in Immunocore in Q3 2022 and held it in 4 quarters.
  • Quantbot Technologies's Immunocore position peaked at $422K in Q4 2022.
  • 138 funds tracked by Wall St. Rank held Immunocore as of Q2 2024.

Based on Quantbot Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.